Tertianum to acquire Senevita: the advisors
French healthcare group Emeis has signed agreements with buyer Tertianum for the sale of Senevita, its Swiss residential and nursing home business. In connection with the deal, Bär & Karrer advised Tertianum, while Lenz & Staehelin represented Emeis.
The Swiss Competition Commission (COMCO) has approved the transaction, which involves two Swiss providers in the field of residential care and nursing for the elderly. Closing is planned for the first quarter of 2026.
The Bär & Karrer team
Christoph Neeracher (pictured left) and Philippe Seiler (pictured right) led the Bär & Karrer team on the matter, working alongside Ronny Schmid, Yascha Fengler, Luca Jagmetti, Björn Wegberg, Markus G. Mezger, and Leo Schall (all M&A), Susanne Schreiber, Martin Leu, Cyrill Diefenbacher, and Aron Liechti (all tax), Corrado Rampini, Patrick Neher, Fanny Cattaneo, and Hannah Birchmeier (all real estate), Mani Reinert, Martin P. Werner, Li Wei Dutler, and Pietro Calcagni (all antitrust), Laura Widmer and Luljeta Morina (both employment), Markus Wang and Christine Schweikard (both IP/IT), Ruth Bloch- Riemer and Sébastien Di Natale (both pensions), as well as Lukas Roesler (financing).
The Lenz & Staehelin team
Partner Roman Graf (corporate and M&A, pictured) led the Lenz & Staehelin team on the matter, with support from partner Lukas Aebi (tax), Federico Trabaldo Togna, Vera Waldburger and Caroline Kopp (corporate and M&A), Stephan Brandner, Maximilien De Ridder, Joshua Lehmann, Lena-Marie Clodong, and Louis Probst (tax), Nathalie Adank and Julia Clara Wepfer (real estate), Benoît Merkt, Valentin Müller and Erica Russo (competition and foundation), Sara Rousselle, Jacomo Restellini, and Justine Membrez (employment), and Lukas Staub (IT), among others.
